unclear. There is limited understanding of what forms of tau confer its toxicity and how tau aggregates interfere with cellular function leading to neurodegeneration. The main reason for this gap in our knowledge comes from the complexity of tau proteins and the heterogeneous patterns of tau pathology presented in different tauopathies. Different isoforms are affected in different tauopathies leading to aggregates with distinct structures, which accumulate in different cell types.
